(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Sangamo Therapeutics, Synchronoss Technologies, and Discover Financial Services.

The three biggest losers today are FibroGen, SunPower Corporation, and Aurora Cannabis.

Winners today

1. Sangamo Therapeutics (SGMO) – 31.43%

Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.

NASDAQ ended the session with Sangamo Therapeutics jumping 31.43% to $1.38 on Tuesday, after three successive sessions in a row of gains. NASDAQ dropped 0.92% to $15,630.78, following the last session’s downward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Sangamo Therapeutics has a trailing twelve months EPS of $-1.46.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112.37%.

Volume

Today’s last reported volume for Sangamo Therapeutics is 13559800 which is 604.36% above its average volume of 1925110.

Sales Growth

Sangamo Therapeutics’s sales growth is negative 70.3% for the present quarter and negative 95.5% for the next.

More news about Sangamo Therapeutics.

2. Synchronoss Technologies (SNCR) – 17.17%

Synchronoss Technologies, Inc. provides cloud, digital, messaging, and network management platforms, products, and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its platforms, products, and solutions include cloud sync, backup, storage, device set up, content transfer, and content engagement for user generated content; multi-channel messaging peer-to-peer communications and application-to-person commerce solutions; customer journey and workflow design, development, orchestration, and experience management solutions; and telecom network infrastructure designing, procuring, managing, and optimizing solutions. In addition, the company offers software development and customization services. It markets and sells its services through direct sales force and strategic partners. Synchronoss Technologies, Inc. was incorporated in 2000 and is headquartered in Bridgewater, New Jersey.

NASDAQ ended the session with Synchronoss Technologies jumping 17.17% to $10.78 on Tuesday while NASDAQ fell 0.92% to $15,630.78.

Earnings Per Share

As for profitability, Synchronoss Technologies has a trailing twelve months EPS of $-4.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.88%.

Moving Average

Synchronoss Technologies’s value is way higher than its 50-day moving average of $5.98 and way above its 200-day moving average of $7.14.

Volume

Today’s last reported volume for Synchronoss Technologies is 425645 which is 410.37% above its average volume of 83398.

More news about Synchronoss Technologies.

3. Discover Financial Services (DFS) – 12.91%

Discover Financial Services, through its subsidiaries, provides digital banking products and services, and payment services in the United States. It operates in two segments, Digital Banking and Payment Services. The Digital Banking segment offers Discover-branded credit cards to individuals; private student loans, personal loans, home loans, and other consumer lending; and direct-to-consumer deposit products comprising savings accounts, certificates of deposit, money market accounts, IRA certificates of deposit, IRA savings accounts and checking accounts, and sweep accounts. The Payment Services segment operates the PULSE, an automated teller machine, debit, and electronic funds transfer network; and Diners Club International, a payments network that issues Diners Club branded charge cards and/or provides card acceptance services, as well as offers payment transaction processing and settlement services. The company was incorporated in 1960 and is based in Riverwoods, Illinois.

NYSE ended the session with Discover Financial Services jumping 12.91% to $124.75 on Tuesday while NYSE fell 0.49% to $17,324.73.

Earnings Per Share

As for profitability, Discover Financial Services has a trailing twelve months EPS of $11.26.

PE Ratio

Discover Financial Services has a trailing twelve months price to earnings ratio of 11.08. Meaning, the purchaser of the share is investing $11.08 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.99%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Discover Financial Services’s stock is considered to be oversold (<=20).

Volatility

Discover Financial Services’s last week, last month’s, and last quarter’s current intraday variation average was 0.64%, 0.48%, and 1.48%.

Discover Financial Services’s highest amplitude of average volatility was 0.78% (last week), 1.33% (last month), and 1.48% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 13.1% and a negative 24.3%, respectively.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Feb 21, 2024, the estimated forward annual dividend rate is 2.8 and the estimated forward annual dividend yield is 2.53%.

More news about Discover Financial Services.

4. Aspen Group (ASPU) – 9.89%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group rising 9.89% to $0.19 on Tuesday while NASDAQ dropped 0.92% to $15,630.78.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.95%.

Sales Growth

Aspen Group’s sales growth is negative 24% for the present quarter and negative 29.3% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 19%, now sitting on 58.83M for the twelve trailing months.

More news about Aspen Group.

5. Quidel (QDEL) – 9.88%

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies and solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

NASDAQ ended the session with Quidel rising 9.88% to $45.88 on Tuesday while NASDAQ slid 0.92% to $15,630.78.

Earnings Per Share

As for profitability, Quidel has a trailing twelve months EPS of $-0.15.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.2%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is a negative 40.6% and positive 57.7% for the next.

More news about Quidel.

6. Sarepta Therapeutics (SRPT) – 7.78%

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. It also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer (PMO) chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. The company has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. It also has a research and option agreement with Codiak BioSciences, Inc. to design and develop engineered exosome therapeutics to deliver gene therapy, gene editing, and RNA technologies for neuromuscular diseases; and research collaboration with Genevant Sciences for lipid nanoparticle-based gene editing therapeutics. Sarepta Therapeutics, Inc. was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Sarepta Therapeutics jumping 7.78% to $134.61 on Tuesday while NASDAQ dropped 0.92% to $15,630.78.

Earnings Per Share

As for profitability, Sarepta Therapeutics has a trailing twelve months EPS of $-7.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -115.61%.

More news about Sarepta Therapeutics.

7. Smith Micro Software (SMSI) – 5.97%

Smith Micro Software, Inc. develops and sells software to enhance the mobile experience to wireless and cable service providers worldwide. The company provides SafePath Family, SafePath IoT, and SafePath Home product suite that offers tools to protect digital lifestyles and manage connected devices inside and outside the home; and CommSuite that allows users to manage voice messages, as well as voice-to-text transcription messaging. In addition, the company provides ViewSpot, a retail display management platform that provides on-screen and interactive demos to wireless carriers and retailers, as well as technical support and customer services. Smith Micro Software, Inc. was founded in 1982 and is headquartered in Pittsburgh, Pennsylvania.

NASDAQ ended the session with Smith Micro Software jumping 5.97% to $0.81 on Tuesday while NASDAQ slid 0.92% to $15,630.78.

Earnings Per Share

As for profitability, Smith Micro Software has a trailing twelve months EPS of $-0.42.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -32.01%.

More news about Smith Micro Software.

8. Origin Agritech Limited (SEED) – 5.76%

Origin Agritech Limited, together with its subsidiaries, operates an agricultural biotechnology and an e-commerce platform in the People's Republic of China. The company engages in crop seed breeding and genetic improvement activities. It develops, produces, and distributes hybrid crop seeds, as well as develops hybrid seed technology. The company also operates an e-commerce platform, which provides range of products, including agricultural seed products that comprise corn, rice, and vegetable seeds; other agricultural inputs, such as fertilizers and agricultural chemicals; foods; household products; and other consumer products to farmers through online and mobile ordering. It has a collaboration agreement with Chinese Academy of Agricultural Sciences, the National Maize Improvement Center, China Agricultural University, and Zhejiang University. Origin Agritech Limited was founded in 1997 and is headquartered in Beijing, China.

NASDAQ ended the session with Origin Agritech Limited rising 5.76% to $2.57 on Tuesday while NASDAQ slid 0.92% to $15,630.78.

Earnings Per Share

As for profitability, Origin Agritech Limited has a trailing twelve months EPS of $1.17.

PE Ratio

Origin Agritech Limited has a trailing twelve months price to earnings ratio of 2.2. Meaning, the purchaser of the share is investing $2.2 for every dollar of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth grew by 338%, now sitting on 93.31M for the twelve trailing months.

Volume

Today’s last reported volume for Origin Agritech Limited is 44404 which is 19.27% above its average volume of 37227.

More news about Origin Agritech Limited.

9. SuperCom, Ltd. (SPCB) – 4.93%

SuperCom Ltd. provides digital identity, Internet of Things and connectivity, and cyber security products and solutions to governments, and private and public organizations worldwide. The company offers MAGNA, a common platform for ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management. Its PureRF suite is a solution based on RFID tag technology to identify, locate, track, monitor, count, and protect people and objects. The company's PureRF suite comprises PureRF tags, hands-free long-range RFID asset and vehicle tags, PureRF readers, PureRF activators, and PureRF initializers. It also provides house arrest monitoring systems, PureTag RF bracelets, PureCom RF base stations, GPS offender tracking systems, PureTrack, PureBeacon, PureMonitor offender electronic monitoring software, inmate monitoring systems, DoorGuard tracking station, and personnel tags. In addition, the company offers domestic violence victim protection systems. Further, it provides connectivity products and solutions comprising AVIDITY WBSac, BOLSTER WBSn, BreezeULTRA P6000, Arena controller, and BreezeNET B. Additionally, the company offers Safend's Encryption Suite that protects the organization's sensitive data; and designs solutions for carrier Wi-Fi, enterprise connectivity, smart city, smart hospitality, connected campuses, and connected events. SuperCom Ltd. sells its systems and products through local representatives, subsidiaries, and distribution channels, as well as independent representatives and resellers. The company was formerly known as Vuance Ltd. and changed its name to SuperCom Ltd. in January 2013. SuperCom Ltd. was incorporated in 1988 and is headquartered in Tel Aviv-Yafo, Israel.

NASDAQ ended the session with SuperCom, Ltd. rising 4.93% to $0.18 on Tuesday while NASDAQ slid 0.92% to $15,630.78.

Earnings Per Share

As for profitability, SuperCom, Ltd. has a trailing twelve months EPS of $-0.99.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -57.42%.

Volume

Today’s last reported volume for SuperCom, Ltd. is 1361940 which is 23.73% below its average volume of 1785760.

Moving Average

SuperCom, Ltd.’s worth is way under its 50-day moving average of $0.30 and way below its 200-day moving average of $0.61.

Sales Growth

SuperCom, Ltd.’s sales growth is negative 26.6% for the ongoing quarter and 7.4% for the next.

More news about SuperCom, Ltd..

10. ConAgra Foods (CAG) – 4.39%

Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company primarily in the United States. The company operates through Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice segments. The Grocery & Snacks segment primarily offers shelf stable food products through various retail channels. The Refrigerated & Frozen segment provides temperature-controlled food products through various retail channels. The International segment offers food products in various temperature states through retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, including meals, entrees, sauces, and various custom-manufactured culinary products packaged for restaurants and other foodservice establishments. The company sells its products under the Birds Eye, Marie Callender's, Duncan Hines, Healthy Choice, Slim Jim, Reddi-wip, Angie's, BOOMCHICKAPOP, Duke's, Earth Balance, Gardein, and Frontera brands. The company was incorporated in 1919 and is headquartered in Chicago, Illinois.

NYSE ended the session with ConAgra Foods rising 4.39% to $28.41 on Tuesday, after two successive sessions in a row of gains. NYSE dropped 0.49% to $17,324.73, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, ConAgra Foods has a trailing twelve months EPS of $2.05.

PE Ratio

ConAgra Foods has a trailing twelve months price to earnings ratio of 13.86. Meaning, the purchaser of the share is investing $13.86 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.06%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ConAgra Foods’s EBITDA is 1.82.

Moving Average

ConAgra Foods’s value is below its 50-day moving average of $28.98 and below its 200-day moving average of $30.77.

Sales Growth

ConAgra Foods’s sales growth for the next quarter is negative 0.4%.

More news about ConAgra Foods.

Losers Today

1. FibroGen (FGEN) – -19.25%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen sliding 19.25% to $1.77 on Tuesday, following the last session’s upward trend. NASDAQ slid 0.92% to $15,630.78, following the last session’s downward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-3.09.

Moving Average

FibroGen’s value is way higher than its 50-day moving average of $1.18 and way below its 200-day moving average of $4.10.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 40% and 50.6%, respectively.

More news about FibroGen.

2. SunPower Corporation (SPWR) – -15.42%

SunPower Corporation delivers solar solutions worldwide. It operates through Residential, Light Commercial; Commercial and Industrial Solutions; and Others segments. The company provides solar energy solutions, including sales to its third-party dealer network and resellers, storage solutions, cash and loan sales, and long-term leases directly to end customers; and sells turn-key engineering, procurement, and construction services, as well as sells energy under power purchase agreements. It also offers commercial roof, carport, and ground mounted systems; and post-installation operations and maintenance services. In addition, the company provides residential leasing program services, as well as sells inverters manufactured by third parties. The company also serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. The company was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activités USA.

NASDAQ ended the session with SunPower Corporation sliding 15.42% to $3.62 on Tuesday while NASDAQ fell 0.92% to $15,630.78.

Earnings Per Share

As for profitability, SunPower Corporation has a trailing twelve months EPS of $-1.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -51.44%.

Sales Growth

SunPower Corporation’s sales growth for the next quarter is negative 22.3%.

Yearly Top and Bottom Value

SunPower Corporation’s stock is valued at $3.62 at 16:32 EST, way under its 52-week high of $16.42 and way higher than its 52-week low of $2.74.

More news about SunPower Corporation.

3. Aurora Cannabis (ACB) – -12.1%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis sliding 12.1% to $3.45 on Tuesday, after four consecutive sessions in a row of losses. NYSE dropped 0.49% to $17,324.73, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-59.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.67%.

Moving Average

Aurora Cannabis’s value is way higher than its 50-day moving average of $0.47 and way higher than its 200-day moving average of $0.54.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 84.6% and 86.7%, respectively.

More news about Aurora Cannabis.

4. 2U (TWOU) – -10.3%

2U, Inc. operates as an education technology company in the United States, Hong Kong, South Africa, and the United Kingdom. The company operates in two segments, Degree Program and Alternative Credential. The Degree Program segment provides the technology and services to nonprofit colleges and universities to enable the online delivery of degree programs. This segment targets students seeking an undergraduate or graduate degree. The Alternative Credential segment offers online short courses, and technical and skills-based boot camps through nonprofit colleges and universities. This segment targets students seeking to reskill or upskill through shorter duration and lower-priced offerings. It also provides 2UOS, a platform that provides front-end and back-end cloud-based SaaS technology and technology-enabled services. The company was formerly known as 2Tor Inc. and changed its name to 2U, Inc. in October 2012. 2U, Inc. was founded in 2008 and is headquartered in Lanham, Maryland.

NASDAQ ended the session with 2U dropping 10.3% to $0.42 on Tuesday while NASDAQ fell 0.92% to $15,630.78.

Earnings Per Share

As for profitability, 2U has a trailing twelve months EPS of $-3.93.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -88.16%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 230% and positive 38.9% for the next.

More news about 2U.

5. Marathon (MARA) – -10.1%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon dropping 10.1% to $24.22 on Tuesday, after two successive sessions in a row of losses. NASDAQ fell 0.92% to $15,630.78, following the last session’s downward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-3.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

More news about Marathon.

6. DouYu (DOYU) – -9.37%

DouYu International Holdings Limited, together with its subsidiaries, operates a platform on PC and mobile apps that provides interactive games and entertainment live streaming services in the People's Republic of China. Its platform connects game developers and publishers, professional eSports teams or players and eSports tournament organizers, advertisers, and viewers. The company also sponsors professional players and teams, and organizes eSports tournaments. In addition, it streams other content to include a spectrum of live streaming entertainment options, such as talent shows, music, outdoor, and travel. Further, the company records and offers video clips to allow users to watch replays of selective live streaming content. DouYu International Holdings Limited was founded in 2014 and is headquartered in Wuhan, the People's Republic of China.

NASDAQ ended the session with DouYu dropping 9.37% to $0.72 on Tuesday while NASDAQ dropped 0.92% to $15,630.78.

Earnings Per Share

As for profitability, DouYu has a trailing twelve months EPS of $0.06.

PE Ratio

DouYu has a trailing twelve months price to earnings ratio of 12.02. Meaning, the purchaser of the share is investing $12.02 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.08%.

Yearly Top and Bottom Value

DouYu’s stock is valued at $0.72 at 16:32 EST, way below its 52-week high of $1.46 and higher than its 52-week low of $0.70.

Volatility

DouYu’s last week, last month’s, and last quarter’s current intraday variation average was a positive 3.30%, a negative 0.08%, and a positive 3.41%.

DouYu’s highest amplitude of average volatility was 3.39% (last week), 3.23% (last month), and 3.41% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, DouYu’s stock is considered to be oversold (<=20).

More news about DouYu.

7. Canaan (CAN) – -8.91%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.

NASDAQ ended the session with Canaan sliding 8.91% to $2.10 on Tuesday while NASDAQ dropped 0.92% to $15,630.78.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $-0.47.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.23%.

Volume

Today’s last reported volume for Canaan is 29533500 which is 49.14% above its average volume of 19801800.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 30.8% and 75%, respectively.

More news about Canaan.

8. UFP Industries (UFPI) – -8.28%

UFP Industries, Inc., through its subsidiaries, designs, manufactures, and markets wood and wood-alternative products in North America, Europe, Asia, and Australia. The company offers preserved and unpreserved dimensional lumber; outdoor living products, including wood and wood composite decking and related accessories, and decorative lawn and garden products; and engineered wood components, which include roof and floor trusses, wall panels, engineered floor systems, I-joists, and lumber packages. It also provides pallets, specialty crates, wooden boxes, and other containers and products that are used for packaging, shipping, and material handling applications; designs, manufactures, and installs interior fixtures that are used in retail and commercial structures; and provides lumber cut and shaped, plywood, oriented strand board, and dimensional lumber products for use in the construction of manufactured housings. In addition, the company supplies siding, electrical, and plumbing products to manufactured housing and recreational vehicle customers; and wood forms and related products to set or form concrete for various structures, such as parking garages, stadiums, and bridges. Further, it provides framing services; and specialty wood packaging, components, and packing materials for various industries. The company primarily sells its products under the roWood, Deckorators, UFP-Edge, Outdoor Essentials, Dimensions, and ProWood FR trademarks. The company was formerly known as Universal Forest Products, Inc. and changed its name to UFP Industries, Inc. in April 2020. UFP Industries, Inc. was founded in 1955 and is headquartered in Grand Rapids, Michigan.

NASDAQ ended the session with UFP Industries sliding 8.28% to $108.81 on Tuesday while NASDAQ dropped 0.92% to $15,630.78.

UFP industries (ufpi) misses Q4 earnings and revenue estimatesWhile UFP Industries has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

Earnings Per Share

As for profitability, UFP Industries has a trailing twelve months EPS of $8.53.

PE Ratio

UFP Industries has a trailing twelve months price to earnings ratio of 12.76. Meaning, the purchaser of the share is investing $12.76 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.97%.

Volume

Today’s last reported volume for UFP Industries is 173661 which is 34.33% below its average volume of 264471.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Feb 29, 2024, the estimated forward annual dividend rate is 1.32 and the estimated forward annual dividend yield is 1.11%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

UFP Industries’s EBITDA is 28.58.

More news about UFP Industries.

9. Pacific Biosciences of California (PACB) – -8.1%

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California falling 8.1% to $5.28 on Tuesday while NASDAQ dropped 0.92% to $15,630.78.

Earnings Per Share

As for profitability, Pacific Biosciences of California has a trailing twelve months EPS of $-1.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -48.53%.

Moving Average

Pacific Biosciences of California’s worth is way below its 50-day moving average of $7.87 and way below its 200-day moving average of $9.96.

More news about Pacific Biosciences of California.

10. Canopy Growth (CGC) – -7.72%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth falling 7.72% to $3.53 on Tuesday, after five sequential sessions in a row of gains. NASDAQ slid 0.92% to $15,630.78, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.77.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.56%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Canopy Growth’s EBITDA is 2.

Volume

Today’s last reported volume for Canopy Growth is 2743170 which is 13.08% below its average volume of 3156270.

More news about Canopy Growth.

Stay up to date with our winners and losers daily report